Clinical trial
Antibiotic Treatment of Gulf War Veterans' Illnesses
NCT00007735 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00007735 |
|---|---|
| Title | Antibiotic Treatment of Gulf War Veterans' Illnesses |
| Official title | CSP #475 - Persian Gulf - Antibiotic Treatment Trial of Gulf War Veterans' Illnesses |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Pfizer Industry United States Department of Defense U.S. Fed |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Persian Gulf Syndrome, Mycoplasma Infections |
| Intervention type | Drug |
| Interventions | Doxycycline (200mg/day) or Placebo |
| Enrollment | 450 |
| Start date | Jan 1, 1999 |
| Completion | Oct 1, 2001 |
| First posted | Jan 1, 2001 |
| Last update posted | Oct 30, 2023 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: